로딩 중...
52주 최고가 대비 86.7% 위치
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $8.13B | $8.20B | $8.25B | $8.32B |
| 영업이익 | - | $1.69B | $1.64B | $1.04B | $632.0M |
| 당기순이익 | - | $1.34B | $1.35B | $479.0M | $1.56B |
| 잉여현금흐름 (FCF) | - | $1.43B | $1.63B | $805.0M | $-10.0M |
| 수익성 비율 | |||||
| 영업이익률 | - | 20.8% | 20.0% | 12.6% | 7.6% |
| 순이익률 | - | 16.5% | 16.4% | 5.8% | 18.7% |
| ROE (자기자본이익률) | - | 11.4% | 11.5% | 16.2% | 30.8% |
| ROA (자산이익률) | - | 9.9% | 9.7% | 3.3% | 10.9% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | 0.8% | 0.7% | 0.9% |
| EPS 성장률 (YoY) | - | - | 0.2% | -64.6% | 221.7% |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | - | - | - | 26.8x | 8.7x |
| PBR (주가순자산배수) | - | - | - | 4.3x | 2.6x |
| PSR (주가매출배수) | - | - | - | 1.6x | 1.6x |
| FCF Yield | - | - | - | 6.3% | -0.1% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | - | 0.71 | 2.71 | 1.00 |
| 유동비율 | - | 1.70 | 1.46 | 1.20 | 1.23 |
MOLINA HEALTHCARE INC
$179.86
$9.4B